Wednesday, February 12, 2025
spot_img

NEURONES: 8.6% organic growth in 2024

PRESS INFORMATION
Heading: 2024 annual revenues        Nanterre, February 12, 2025 (after trading)

8.6% organic growth in 2024

(being audited, in € millions) 2023 2024 Growth of which organic
Revenues 741.2 810.4 + 9.3% + 8.6%

Achievements

Forecasts for the year were exceeded, both in terms of activity and operating profit:

  • revenues totaled €810.4 million, up 9.3% (with 8.1% growth in Q4 );
  • operating profit represented 9.6% of revenues (€77.9 million *).

With double-digit growth, the Group’s expansion is driven by digital projects, data, cybersecurity, public clouds, sovereign ans trusted clouds (SecNumCloud).

The Group’s net increase in the payroll of 340 by 2024 has been supplemented by greater use of subcontracting.

The full final annual results will be published on Wednesday, March 5, 2025 after the stock exchange closes.

Outlook

As usual, the forecasts for 2025 will be posted along with the Group’s Q1 revenues.

* being audited.

About NEURONES
With 7,100 experts, and ranking among the French leaders in consulting and digital services, NEURONES helps large companies and organizations implement their digital projects, transform their IT infrastructures and adopt new uses.

Euronext Paris (compartment B – NRO) – Euronext Tech Leaders – DSS mid-caps – ‘PEA-PME’ eligible
www.neurones.net

Press Relations:
O’Connection
Julia Philippe-Brutin
Tel.: +33 (0)6 03 63 06 03

[email protected]

NEURONES
Matthieu Vautier
Tel.: +33 (0)1 41 37 41 37
[email protected]

Investor Relations:
NEURONES
Paul-César Bonnel
Tel.: +33 (0)1 41 37 41 37
[email protected]

Attachment

  • neurones-2024-annual-revenues

Powered by SlickText.com

Hot this week

Nokia Corporation: Repurchase of own shares on 12.02.2025

Nokia CorporationStock Exchange Release12 February 2025 at 22:30 EET...

Awards under Restricted Share Unit Plan

Reykjavík, Feb. 12, 2025 (GLOBE NEWSWIRE) --...

CVRx announces new real-world evidence demonstrating significant reductions in healthcare utilization with Barostim

New real-world evidence presented at THT 2025 and published...

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

ORION CORPORATION STOCK EXCHANGE RELEASE – MAJOR SHAREHOLDER ANNOUNCEMENTS12...

Topics

spot_img

Related Articles

Popular Categories

spot_img